최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Annales de cardiologie et d'angéiologie, v.69 no.6, 2020년, pp.355 - 359
Hakim, R. (Service de cardiologie, hô) , Motreff, P. (pitaux de Chartres) , Rangé, G. (Service de cardiologie, centre hospitalo-universitaire Gabriel-Montpied)
Abstract The COVID-19 pandemic had an unexpected impact on cardiovascular emergencies, particularly STEMI. The France PCI registry and other studies around the world have highlighted a significant decrease in myocardial infarctions arriving at hospital. This decrease is mainly related to patients&r...
Résumé La pandémie du COVID-19 a eu un impact inattendu sur les urgences cardiovasculaires, en particulier le SCA ST+. Le registre France PCI et d’autres études à travers le monde ont mis en exergue une baisse notable des infarctus arrivant dans les structures hospitalières. Cette baisse est principalement liée à la peur des patients de venir à l’hôpital et d’y être contaminés. Si les objectifs de délais de revascularisation du SCA ST+ (<120min) sont souvent difficiles à tenir en temps normal, ils ont été quasi impossibles à atteindre en période de confinement, tant les obstacles étaient nombreux. L’allongement des délais et du temps total d’ischémie a conduit à une surmortalité, notamment dans les régions les plus affectées par l’épidémie. Des recommandations de prise en charge des SCA ST+ en période de COVID-19 ont ainsi été édictées par les sociétés savantes. Les SCA ST+ chez les patients porteurs du COVID-19 ont souvent une présentation clinique particulière et l’absence d’obstruction coronaire à l’angiographie est fréquente. Leur pronostic est très sombre. Seules des campagnes d’information du public et une organisation adaptée à la prise en charge des urgences coronaires en période épidémique pourront tenter d’en limiter les effets et éviter d’aggraver à l’avenir une situation sanitaire déjà fragilisée.
1 Range G. Hakim R. Motreff P. Where have the ST-elevation myocardial infarction gone during COVID-19?lockdown? Eur H J Qual Care Clin Outcomes 6 2020 223 224
2 Wood S. The mystery of the missing STEMIs during the COVID-19?pandemic 2020 [ https://www.tctmd.com/news/mystery-missing-stemis-during-covid-19-pandemic ; consulte le 05?aout 2020]
3 Metzler B. Siostrzonek P. Binder R.K. Bauer A. Reinstadler S.J. Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage Eur Heart J 2020 10.1093/eurheartj/ehaa314
4 De Rosa S. Spaccarotella C. Basso C. Calabro M.P. Curcio A. Filardi P.P. Reduction of hospitalisations for myocardial infarction in Italy in the COVID-19?era Eur Heart J 41 2020 2083 2088 32412631
5 Rodriguez-Leor O. Cid-Alvarez B. Ojeda S. Martin-Moreiras J. Rumoroso J.R. Lopez-Palop R. Impact of the COVID-19?pandemic on interventional cardiology activity in Spain REC Interv Cardiol 2 2020 82 89
6 Solomon M.D. McNulty E.J. Rana J.S. Leong T.K. Ambrosy A.P. Sidney S. The COVID-19?pandemic and the incidence of acute myocardial infarction N Engl J Med 383 2020 691 693 32427432
7 Xiang D. Xiang X. Zhang W. Yi S. Zhang J. Gu X. Management and outcomes of patients with STEMI during the COVID-19?pandemic in China J Am Coll Cardiol 2020 10.1016/j.jacc.2020.06.039
8 Mustafic H. Jabre P. Caussin C. Murad M.H. Escolano S. Tafflet M. Main air pollutants and myocardial infarction: a systematic review and meta-analysis JAMA 307 2012 713 721 22337682
9 Caussin C. Escolano S. Mustafic H. Bataille S. Tafflet M. Chatignoux E. Short-term exposure to environmental parameters and onset of ST-elevation myocardial infarction. The CARDIO-ARSIF registry Int J Cardiol 183 2015 17 23 25662048
10 Chan-Chee C. Leon C. Lasbeur L. Lecrique J.M. Raude J. Arwidson P. The mental health of the French facing the COVID-19?crisis: prevalence, evolution and determinants of anxiety disorders during the first two weeks of lockdown COVIPREV study, 23?25?March and 30?March?1?April, 2020 Bull Epidemiol Hebd 13 2020 260 269
11 Chieffo A. Stefanini G.G. Price S. Barbato E. Tarantini G. Karam N. EAPCI position statement on invasive management of acute coronary syndromes during the COVID-19?pandemic Eur Heart J 41 2020 1839 1851 32405641
12 Andreini D. Arbelo E. Barbato E. Bartorelli A. Baumbach A. Behr E. ESC guidance for the diagnosis and management of CV disease during the COVID-19?pandemic 2020 [ https://www.escardio.org/static-file/Escardio/Education-General/Topic%20pages/Covid-19/ESC%20Guidance%20Document/ESC-Guidance-COVID-19-Pandemic.pdf ; consulte le 5?septembre 2020]
13 Roffi M. Guagliumi G. Ibanez B. The obstacle course of reperfusion for STEMI in the COVID-19?pandemic Circulation 141 2020 1951 1953 32315205
14 Coughlan J.J. Chongprasertpon N. Arockiam S. Arnous S. Kiernan T.J. COVID-19?and STEMI: a snapshot analysis of presentation patterns during a pandemic Int J Cardiol Heart Vasc 2020 10.1016/j.ijcha.2020.100546
15 De Luca G. Suryapranata H. Ottervanger J.P. Antman E.M. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts Circulation 109 2004 1223 1225 15007008
16 Daoulah A. Hersi A.S. Al-Faifi S.M. Alasmari A. Aljohar A. Balghith M. STEMI and COVID-19?pandemic in Saudi Arabia Curr Probl Cardiol 2020 10.1016/j.cpcardiol.2020.100656
17 Huang C. Wang Y. Li X. Ren L. Zhao J. Hu Y. Clinical features of patients infected with 2019?novel coronavirus in Wuhan, China Lancet 395 2020 497 506 31986264
18 Shi S. Qin M. Shen B. Cai Y. Liu T. Yang F. Association of cardiac injury with mortality in hospitalised patients with COVID-19?in Wuhan, China JAMA Cardiol 5 2020 802 810 32211816
19 Stefanini G.G. Chieffo A. ST-elevation myocardial infarction in patients with COVID-19. Clinical and angiographic outcomes Circulation 141 2020 2113 2116 32352306
20 Bangalore S. Sharma A. Slotwiner A. Yatskar L. Harari R. Shah B. ST-segment elevation in patients with COVID-19 ? a case series N Engl J Med 382 2020 2478 2480 32302081
21 Tavazzi G. Pellegrini C. Maurelli M. Belliato M. Sciutti F. Bottazzi A. Myocardial localisation of coronavirus in COVID-19?cardiogenic shock Eur J Heart Fail 22 2020 911 915 32275347
22 Inciardi R.M. Lupi L. Zaccone G. Italia L. Raffo M. Tomasoni D. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) JAMA Cardiol 27 2020 1 6
23 Kim I.C. Kim J.Y. Kim H.A. Han S. COVID-19?related myocarditis in a 21-year old female patient Eur Heart J 41 2020 1859 32282027
24 Paul J.F. Carles P. Richaud C. Caussin C. Diakov C. Myocarditis revealing COVID-19?infection in a young patient Eur Heart J Cardiovasc Imaging 21 2020 776 32338706
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.